A Food and Drug Administration advisory panel unanimously voted to recommend Moderna (MRNA) - Get Moderna, Inc. Report COVID booster shots for emergency use in individuals aged 65+ and vulnerable populations.
Following a clinical trial of roughly 170 adults, Moderna said half the dosage of its first two shots produced a strong immune response.
The FDA is expected to issue a final decision in a few days. Once the FDA gives the green light, the Centers for Disease Control and Prevention (CDC) will issue a final recommendation. The Moderna booster shots would be available immediately after the CDC endorsement.